For US residents only.

×

Zero in on what may make your metastatic non-small cell lung cancer unique

A comprehensive biomarker test can help you and your doctor zero in on the right metastatic non-small cell lung cancer (mNSCLC) treatment for you.

 

Find out more

Comprehensive Biomarker Testing for mNSCLC

Ask your doctor to test for different traits of your specific type of cancer, such as PD-L1 levels or mutations like EGFR, ALK, and METex14.

See testing options

 

ALK, anaplastic lymphoma kinase; EGFR, epidermal growth factor receptor; MET,  mesenchymal-epithelial transition; METex14, MET exon 14 skipping; PD-L1,  programmed death-ligand 1.

Find the right treatment for you

Your test results may help your doctor find a treatment path specific to your mNSCLC, whether it includes targeted therapy or not.

 

Learn about results

You are now leaving the Novartis site and moving to an external website independently operated and not managed by Novartis Pharmaceuticals Corporation. Novartis assumes no responsibility for the site. If you do not wish to leave this site, click Cancel. Or click OK to continue.

1/17 ONC-1154329

 

 

 
Contact Us Non-US Residents Sitemap

Use of website is governed by the Terms of Use and Privacy Policy.

Copyright © 2021 Novartis Pharmaceuticals Corporation. All rights reserved.

8/21 142273